APO Research
Talk to an analyst

APO RESEARCH · REPORT

TYK2 Targeting Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global TYK2 Targeting Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025196 pages

Choose your research edition.

Industry ResearchTYK2 Targeting Drugs Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal TYK2 Targeting Drugs Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal TYK2 Targeting Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal TYK2 Targeting Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal TYK2 Targeting Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global TYK2 Targeting Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for TYK2 Targeting Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for TYK2 Targeting Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for TYK2 Targeting Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for TYK2 Targeting Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of TYK2 Targeting Drugs include Inventisbio, Qiyuan Biotechnology, InnoCare, Guangzhou Zaiji Pharmaceutical, Changzhou Hengbang Pharmaceutical, BeiGene, Ventyx Biosciences, Takeda (Nimbus Therapeutics) and Sareum Holdings Pic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global TYK2 Targeting Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of TYK2 Targeting Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents TYK2 Targeting Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the TYK2 Targeting Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

TYK2 Targeting Drugs Segment by Company

Inventisbio

Qiyuan Biotechnology

InnoCare

Guangzhou Zaiji Pharmaceutical

Changzhou Hengbang Pharmaceutical

BeiGene

Ventyx Biosciences

Takeda (Nimbus Therapeutics)

Sareum Holdings Pic

Oncostellae

Galapagos NV

Bristol Myers Squibb

TYK2 Targeting Drugs Segment by Type

Single-target Inhibitors

Dual-target Inhibitors

TYK2 Targeting Drugs Segment by Application

Psoriasis

Systemic Lupus Erythematosus

Dermatitis

Arthritis

Others

TYK2 Targeting Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global TYK2 Targeting Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of TYK2 Targeting Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of TYK2 Targeting Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the TYK2 Targeting Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of TYK2 Targeting Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of TYK2 Targeting Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of TYK2 Targeting Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. TYK2 Targeting Drugs Industry Trends Table 2. TYK2 Targeting Drugs Industry Drivers Table 3. TYK2 Targeting Drugs Industry Opportunities and Challenges Table 4. TYK2 Targeting Drugs Industry Restraints Table 5. Global TYK2 Targeting Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global TYK2 Targeting Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global TYK2 Targeting Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global TYK2 Targeting Drugs Sales Market Share by Manufacturers Table 9. Global TYK2 Targeting Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global TYK2 Targeting Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global TYK2 Targeting Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global TYK2 Targeting Drugs Manufacturers, Product Type & Application Table 13. Global TYK2 Targeting Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global TYK2 Targeting Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Single-target Inhibitors Table 17. Major Manufacturers of Dual-target Inhibitors Table 18. Global TYK2 Targeting Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global TYK2 Targeting Drugs Sales by Type (2021-2026) & (K Units) Table 20. Global TYK2 Targeting Drugs Sales by Type (2027-2032) & (K Units) Table 21. Global TYK2 Targeting Drugs Sales Market Share by Type (2021-2026) Table 22. Global TYK2 Targeting Drugs Sales Market Share by Type (2027-2032) Table 23. Global TYK2 Targeting Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global TYK2 Targeting Drugs Revenue by Type (2021-2026) & (K Units) Table 25. Global TYK2 Targeting Drugs Revenue by Type (2027-2032) & (K Units) Table 26. Global TYK2 Targeting Drugs Revenue Market Share by Type (2021-2026) Table 27. Global TYK2 Targeting Drugs Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Psoriasis Table 29. Major Manufacturers of Systemic Lupus Erythematosus Table 30. Major Manufacturers of Dermatitis Table 31. Major Manufacturers of Arthritis Table 32. Major Manufacturers of Others Table 33. Global TYK2 Targeting Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global TYK2 Targeting Drugs Sales by Application (2021-2026) & (K Units) Table 35. Global TYK2 Targeting Drugs Sales by Application (2027-2032) & (K Units) Table 36. Global TYK2 Targeting Drugs Sales Market Share by Application (2021-2026) Table 37. Global TYK2 Targeting Drugs Sales Market Share by Application (2027-2032) Table 38. Global TYK2 Targeting Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global TYK2 Targeting Drugs Revenue by Application (2021-2026) & (K Units) Table 40. Global TYK2 Targeting Drugs Revenue by Application (2027-2032) & (K Units) Table 41. Global TYK2 Targeting Drugs Revenue Market Share by Application (2021-2026) Table 42. Global TYK2 Targeting Drugs Revenue Market Share by Application (2027-2032) Table 43. Global TYK2 Targeting Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global TYK2 Targeting Drugs Sales by Region (2021-2026) & (K Units) Table 45. Global TYK2 Targeting Drugs Sales Market Share by Region (2021-2026) Table 46. Global TYK2 Targeting Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global TYK2 Targeting Drugs Sales Forecasted Market Share by Region (2027-2032) Table 48. North America TYK2 Targeting Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America TYK2 Targeting Drugs Sales by Country (2021-2026) & (K Units) Table 50. North America TYK2 Targeting Drugs Sales by Country (2027-2032) & (K Units) Table 51. Europe TYK2 Targeting Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe TYK2 Targeting Drugs Sales by Country (2021-2026) & (K Units) Table 53. Europe TYK2 Targeting Drugs Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific TYK2 Targeting Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific TYK2 Targeting Drugs Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific TYK2 Targeting Drugs Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa TYK2 Targeting Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa TYK2 Targeting Drugs Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa TYK2 Targeting Drugs Sales by Country (2027-2032) & (K Units) Table 60. Global TYK2 Targeting Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global TYK2 Targeting Drugs Revenue by Region (2021-2026) & (US$ Million) Table 62. Global TYK2 Targeting Drugs Revenue by Region (2027-2032) & (US$ Million) Table 63. Global TYK2 Targeting Drugs Revenue Market Share by Region (2021-2026) Table 64. Global TYK2 Targeting Drugs Revenue Market Share by Region (2027-2032) Table 65. Inventisbio Company Information Table 66. Inventisbio Business Overview Table 67. Inventisbio TYK2 Targeting Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Inventisbio TYK2 Targeting Drugs Product Portfolio Table 69. Inventisbio Recent Development Table 70. Qiyuan Biotechnology Company Information Table 71. Qiyuan Biotechnology Business Overview Table 72. Qiyuan Biotechnology TYK2 Targeting Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Qiyuan Biotechnology TYK2 Targeting Drugs Product Portfolio Table 74. Qiyuan Biotechnology Recent Development Table 75. InnoCare Company Information Table 76. InnoCare Business Overview Table 77. InnoCare TYK2 Targeting Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. InnoCare TYK2 Targeting Drugs Product Portfolio Table 79. InnoCare Recent Development Table 80. Guangzhou Zaiji Pharmaceutical Company Information Table 81. Guangzhou Zaiji Pharmaceutical Business Overview Table 82. Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Product Portfolio Table 84. Guangzhou Zaiji Pharmaceutical Recent Development Table 85. Changzhou Hengbang Pharmaceutical Company Information Table 86. Changzhou Hengbang Pharmaceutical Business Overview Table 87. Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Product Portfolio Table 89. Changzhou Hengbang Pharmaceutical Recent Development Table 90. BeiGene Company Information Table 91. BeiGene Business Overview Table 92. BeiGene TYK2 Targeting Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. BeiGene TYK2 Targeting Drugs Product Portfolio Table 94. BeiGene Recent Development Table 95. Ventyx Biosciences Company Information Table 96. Ventyx Biosciences Business Overview Table 97. Ventyx Biosciences TYK2 Targeting Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Ventyx Biosciences TYK2 Targeting Drugs Product Portfolio Table 99. Ventyx Biosciences Recent Development Table 100. Takeda (Nimbus Therapeutics) Company Information Table 101. Takeda (Nimbus Therapeutics) Business Overview Table 102. Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Product Portfolio Table 104. Takeda (Nimbus Therapeutics) Recent Development Table 105. Sareum Holdings Pic Company Information Table 106. Sareum Holdings Pic Business Overview Table 107. Sareum Holdings Pic TYK2 Targeting Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Sareum Holdings Pic TYK2 Targeting Drugs Product Portfolio Table 109. Sareum Holdings Pic Recent Development Table 110. Oncostellae Company Information Table 111. Oncostellae Business Overview Table 112. Oncostellae TYK2 Targeting Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Oncostellae TYK2 Targeting Drugs Product Portfolio Table 114. Oncostellae Recent Development Table 115. Galapagos NV Company Information Table 116. Galapagos NV Business Overview Table 117. Galapagos NV TYK2 Targeting Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Galapagos NV TYK2 Targeting Drugs Product Portfolio Table 119. Galapagos NV Recent Development Table 120. Bristol Myers Squibb Company Information Table 121. Bristol Myers Squibb Business Overview Table 122. Bristol Myers Squibb TYK2 Targeting Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Bristol Myers Squibb TYK2 Targeting Drugs Product Portfolio Table 124. Bristol Myers Squibb Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. TYK2 Targeting Drugs Distributors List Table 128. TYK2 Targeting Drugs Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. TYK2 Targeting Drugs Product Image Figure 2. Global TYK2 Targeting Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global TYK2 Targeting Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global TYK2 Targeting Drugs Sales (2021-2032) & (K Units) Figure 5. Global TYK2 Targeting Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 TYK2 Targeting Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Single-target Inhibitors Image Figure 9. Dual-target Inhibitors Image Figure 10. Global TYK2 Targeting Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global TYK2 Targeting Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global TYK2 Targeting Drugs Sales Market Share by Type (2021-2032) Figure 13. Global TYK2 Targeting Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global TYK2 Targeting Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global TYK2 Targeting Drugs Revenue Market Share by Type (2021-2032) Figure 16. Psoriasis Image Figure 17. Systemic Lupus Erythematosus Image Figure 18. Dermatitis Image Figure 19. Arthritis Image Figure 20. Others Image Figure 21. Global TYK2 Targeting Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global TYK2 Targeting Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global TYK2 Targeting Drugs Sales Market Share by Application (2021-2032) Figure 24. Global TYK2 Targeting Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global TYK2 Targeting Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global TYK2 Targeting Drugs Revenue Market Share by Application (2021-2032) Figure 27. North America TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America TYK2 Targeting Drugs Sales Market Share by Country (2021-2032) Figure 29. U.S. TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe TYK2 Targeting Drugs Sales Market Share by Country (2021-2032) Figure 34. Germany TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific TYK2 Targeting Drugs Sales Market Share by Country (2021-2032) Figure 41. China TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa TYK2 Targeting Drugs Sales Market Share by Country (2021-2032) Figure 49. Brazil TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile TYK2 Targeting Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global TYK2 Targeting Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global TYK2 Targeting Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Figure 60. North America TYK2 Targeting Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Europe TYK2 Targeting Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific TYK2 Targeting Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa TYK2 Targeting Drugs Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa TYK2 Targeting Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. TYK2 Targeting Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. TYK2 Targeting Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Single-target Inhibitors
  • Dual-target Inhibitors
Applications
  • Psoriasis
  • Systemic Lupus Erythematosus
  • Dermatitis
  • Arthritis
  • Others
Companies covered
  • Inventisbio
  • Qiyuan Biotechnology
  • InnoCare
  • Guangzhou Zaiji Pharmaceutical
  • Changzhou Hengbang Pharmaceutical
  • BeiGene
  • Ventyx Biosciences
  • Takeda (Nimbus Therapeutics)
  • Sareum Holdings Pic
  • Oncostellae
  • Galapagos NV
  • Bristol Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global TYK2 Targeting Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global TYK2 Targeting Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global TYK2 Targeting Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global TYK2 Targeting Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global TYK2 Targeting Drugs Market Dynamics
  1. 2.1 TYK2 Targeting Drugs Industry Trends
  2. 2.2 TYK2 Targeting Drugs Industry Drivers
  3. 2.3 TYK2 Targeting Drugs Industry Opportunities and Challenges
  4. 2.4 TYK2 Targeting Drugs Industry Restraints
3 TYK2 Targeting Drugs Market by Manufacturers
  1. 3.1 Global TYK2 Targeting Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global TYK2 Targeting Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global TYK2 Targeting Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global TYK2 Targeting Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global TYK2 Targeting Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global TYK2 Targeting Drugs Manufacturers, Product Type & Application
  7. 3.7 Global TYK2 Targeting Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global TYK2 Targeting Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 TYK2 Targeting Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 TYK2 Targeting Drugs Tier 1, Tier 2, and Tier 3
4 TYK2 Targeting Drugs Market by Type
  1. 4.1 TYK2 Targeting Drugs Type Introduction
  2. 4.1.1 Single-target Inhibitors
  3. 4.1.2 Dual-target Inhibitors
  4. 4.2 Global TYK2 Targeting Drugs Sales by Type
  5. 4.2.1 Global TYK2 Targeting Drugs Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global TYK2 Targeting Drugs Sales by Type (2021-2032)
  7. 4.2.3 Global TYK2 Targeting Drugs Sales Market Share by Type (2021-2032)
  8. 4.3 Global TYK2 Targeting Drugs Revenue by Type
  9. 4.3.1 Global TYK2 Targeting Drugs Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global TYK2 Targeting Drugs Revenue by Type (2021-2032)
  11. 4.3.3 Global TYK2 Targeting Drugs Revenue Market Share by Type (2021-2032)
5 TYK2 Targeting Drugs Market by Application
  1. 5.1 TYK2 Targeting Drugs Application Introduction
  2. 5.1.1 Psoriasis
  3. 5.1.2 Systemic Lupus Erythematosus
  4. 5.1.3 Dermatitis
  5. 5.1.4 Arthritis
  6. 5.1.5 Others
  7. 5.2 Global TYK2 Targeting Drugs Sales by Application
  8. 5.2.1 Global TYK2 Targeting Drugs Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global TYK2 Targeting Drugs Sales by Application (2021-2032)
  10. 5.2.3 Global TYK2 Targeting Drugs Sales Market Share by Application (2021-2032)
  11. 5.3 Global TYK2 Targeting Drugs Revenue by Application
  12. 5.3.1 Global TYK2 Targeting Drugs Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global TYK2 Targeting Drugs Revenue by Application (2021-2032)
  14. 5.3.3 Global TYK2 Targeting Drugs Revenue Market Share by Application (2021-2032)
6 Global TYK2 Targeting Drugs Sales by Region
  1. 6.1 Global TYK2 Targeting Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global TYK2 Targeting Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global TYK2 Targeting Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global TYK2 Targeting Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America TYK2 Targeting Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America TYK2 Targeting Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe TYK2 Targeting Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe TYK2 Targeting Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific TYK2 Targeting Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific TYK2 Targeting Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa TYK2 Targeting Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa TYK2 Targeting Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global TYK2 Targeting Drugs Revenue by Region
  1. 7.1 Global TYK2 Targeting Drugs Revenue by Region
  2. 7.1.1 Global TYK2 Targeting Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global TYK2 Targeting Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global TYK2 Targeting Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global TYK2 Targeting Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America TYK2 Targeting Drugs Revenue (2021-2032)
  8. 7.2.2 North America TYK2 Targeting Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe TYK2 Targeting Drugs Revenue (2021-2032)
  11. 7.3.2 Europe TYK2 Targeting Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific TYK2 Targeting Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific TYK2 Targeting Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa TYK2 Targeting Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa TYK2 Targeting Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Inventisbio
  2. 8.1.1 Inventisbio Company Information
  3. 8.1.2 Inventisbio Business Overview
  4. 8.1.3 Inventisbio TYK2 Targeting Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Inventisbio TYK2 Targeting Drugs Product Portfolio
  6. 8.1.5 Inventisbio Recent Developments
  7. 8.2 Qiyuan Biotechnology
  8. 8.2.1 Qiyuan Biotechnology Company Information
  9. 8.2.2 Qiyuan Biotechnology Business Overview
  10. 8.2.3 Qiyuan Biotechnology TYK2 Targeting Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Qiyuan Biotechnology TYK2 Targeting Drugs Product Portfolio
  12. 8.2.5 Qiyuan Biotechnology Recent Developments
  13. 8.3 InnoCare
  14. 8.3.1 InnoCare Company Information
  15. 8.3.2 InnoCare Business Overview
  16. 8.3.3 InnoCare TYK2 Targeting Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 InnoCare TYK2 Targeting Drugs Product Portfolio
  18. 8.3.5 InnoCare Recent Developments
  19. 8.4 Guangzhou Zaiji Pharmaceutical
  20. 8.4.1 Guangzhou Zaiji Pharmaceutical Company Information
  21. 8.4.2 Guangzhou Zaiji Pharmaceutical Business Overview
  22. 8.4.3 Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Product Portfolio
  24. 8.4.5 Guangzhou Zaiji Pharmaceutical Recent Developments
  25. 8.5 Changzhou Hengbang Pharmaceutical
  26. 8.5.1 Changzhou Hengbang Pharmaceutical Company Information
  27. 8.5.2 Changzhou Hengbang Pharmaceutical Business Overview
  28. 8.5.3 Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Product Portfolio
  30. 8.5.5 Changzhou Hengbang Pharmaceutical Recent Developments
  31. 8.6 BeiGene
  32. 8.6.1 BeiGene Company Information
  33. 8.6.2 BeiGene Business Overview
  34. 8.6.3 BeiGene TYK2 Targeting Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 BeiGene TYK2 Targeting Drugs Product Portfolio
  36. 8.6.5 BeiGene Recent Developments
  37. 8.7 Ventyx Biosciences
  38. 8.7.1 Ventyx Biosciences Company Information
  39. 8.7.2 Ventyx Biosciences Business Overview
  40. 8.7.3 Ventyx Biosciences TYK2 Targeting Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ventyx Biosciences TYK2 Targeting Drugs Product Portfolio
  42. 8.7.5 Ventyx Biosciences Recent Developments
  43. 8.8 Takeda (Nimbus Therapeutics)
  44. 8.8.1 Takeda (Nimbus Therapeutics) Company Information
  45. 8.8.2 Takeda (Nimbus Therapeutics) Business Overview
  46. 8.8.3 Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Product Portfolio
  48. 8.8.5 Takeda (Nimbus Therapeutics) Recent Developments
  49. 8.9 Sareum Holdings Pic
  50. 8.9.1 Sareum Holdings Pic Company Information
  51. 8.9.2 Sareum Holdings Pic Business Overview
  52. 8.9.3 Sareum Holdings Pic TYK2 Targeting Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sareum Holdings Pic TYK2 Targeting Drugs Product Portfolio
  54. 8.9.5 Sareum Holdings Pic Recent Developments
  55. 8.10 Oncostellae
  56. 8.10.1 Oncostellae Company Information
  57. 8.10.2 Oncostellae Business Overview
  58. 8.10.3 Oncostellae TYK2 Targeting Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Oncostellae TYK2 Targeting Drugs Product Portfolio
  60. 8.10.5 Oncostellae Recent Developments
  61. 8.11 Galapagos NV
  62. 8.11.1 Galapagos NV Company Information
  63. 8.11.2 Galapagos NV Business Overview
  64. 8.11.3 Galapagos NV TYK2 Targeting Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Galapagos NV TYK2 Targeting Drugs Product Portfolio
  66. 8.11.5 Galapagos NV Recent Developments
  67. 8.12 Bristol Myers Squibb
  68. 8.12.1 Bristol Myers Squibb Company Information
  69. 8.12.2 Bristol Myers Squibb Business Overview
  70. 8.12.3 Bristol Myers Squibb TYK2 Targeting Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Bristol Myers Squibb TYK2 Targeting Drugs Product Portfolio
  72. 8.12.5 Bristol Myers Squibb Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 TYK2 Targeting Drugs Value Chain Analysis
  2. 9.1.1 TYK2 Targeting Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 TYK2 Targeting Drugs Production Mode & Process
  6. 9.2 TYK2 Targeting Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 TYK2 Targeting Drugs Distributors
  9. 9.2.3 TYK2 Targeting Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst